Hughes, 2024 - Google Patents
Transcriptional Co-Activator OCA-B, Pou2af1, as a Regulator of CD4+ T Cell Memory and AutoimmunityHughes, 2024
- Document ID
- 15737073007983488835
- Author
- Hughes E
- Publication year
External Links
Snippet
CD4+ T cells are an essential component of the adaptive immune system, capable of transforming their effector functions to aid in the host response to a variety of pathogens. Memory CD4+ T cells, formed through previous pathogen experience, act as a rapid and …
- 210000001744 T-lymphocyte 0 title abstract description 253
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8053235B2 (en) | Methods of generating antigen-specific CD4+CD25+regulatory T cells, compositions and methods of use | |
Krovi et al. | Invariant natural killer T cell subsets—more than just developmental intermediates | |
Pluchino et al. | Human neural stem cells ameliorate autoimmune encephalomyelitis in non‐human primates | |
Hori | Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells | |
US20240165158A1 (en) | Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases | |
JP7391038B2 (en) | Methods for enhancing the suppressive properties of Treg cells | |
US20220380727A1 (en) | Generation of engineered regulatory t cells | |
Lee et al. | T lymphocyte development and activation in humanized mouse model | |
EP2915880B1 (en) | Mait-like cells and method for manufacturing same | |
KR20230093044A (en) | Generation of CD4+ effector and regulatory T cells from human pluripotent stem cells | |
WO2011068962A1 (en) | Methods for generating t lymphocytes from hematopoietic stem cells | |
Hughes | Transcriptional Co-Activator OCA-B, Pou2af1, as a Regulator of CD4+ T Cell Memory and Autoimmunity | |
WO2018117090A1 (en) | Method for inducing regulatory t cell | |
Eleftheriadis | Investigating interplay between human regulatory T cells and oligodendrocyte lineage cells | |
Cochrane et al. | High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells | |
Ihantola | T-cell dysfunction and autoantigen recognition in type 1 diabetes | |
Im et al. | Giacomo Casella 1, Javad Rasouli 1, Rodolfo Thome 1, Hélène C. Descamps 2, Asrita Vattikonda 1, Larissa Ishikawa 1, Alexandra Boehm 1, Daniel Hwang 1, Weifeng Zhang 1, Dan Xiao 1, Jeongho Park 3, 4, Guang-Xian Zhang 1, Jorge I. Alvarez 3, Abdolmohamad Rostami1and Bogoljub Ciric 1 | |
Xia | The Maintenance of CD4 and CD8 T Cell Response to Persistent Antigens | |
Garnica Caparrós | Transcriptional and epigenetic events underpinning the peptide-MHC-nanoparticle-induced transdifferentiation of T-follicular helper cells into T-regulatory type 1 cells in vivo | |
Hernandez | Cell-Extrinsic and Cell-Intrinsic Regulation of Natural Killer Cell Behavior in Mice | |
Pappalardo | Single-Cell Definition of T Cell Surveillance in Human Cerebrospinal Fluid | |
Wendland | Thymic Stroma and T Cell Development. Impacts of Retinoic Acid Signaling | |
Wolf | New approaches to understand T cell activation and circumvent T cell dysfunction in cancer | |
Sitnik | Phenotypic and functional analysis of the mesenchymal stromal cell compartment in the thymus | |
Mia | Myeloid cells in autoimmune diseases |